AU2019401465A1 - Mitochondrial DNA deletions associated with endometriosis - Google Patents
Mitochondrial DNA deletions associated with endometriosis Download PDFInfo
- Publication number
- AU2019401465A1 AU2019401465A1 AU2019401465A AU2019401465A AU2019401465A1 AU 2019401465 A1 AU2019401465 A1 AU 2019401465A1 AU 2019401465 A AU2019401465 A AU 2019401465A AU 2019401465 A AU2019401465 A AU 2019401465A AU 2019401465 A1 AU2019401465 A1 AU 2019401465A1
- Authority
- AU
- Australia
- Prior art keywords
- nucleotide
- nucleotides
- mtdna
- deletion
- endometriosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2026202367A AU2026202367A1 (en) | 2018-12-22 | 2026-03-27 | Mitochondrial DNA deletions associated with endometriosis |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862784403P | 2018-12-22 | 2018-12-22 | |
| US62/784,403 | 2018-12-22 | ||
| US201962931173P | 2019-11-05 | 2019-11-05 | |
| US62/931,173 | 2019-11-05 | ||
| PCT/US2019/068098 WO2020132596A2 (en) | 2018-12-22 | 2019-12-20 | Mitochondrial dna deletions associated with endometriosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2026202367A Division AU2026202367A1 (en) | 2018-12-22 | 2026-03-27 | Mitochondrial DNA deletions associated with endometriosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2019401465A1 true AU2019401465A1 (en) | 2021-07-22 |
Family
ID=69185737
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2019401465A Abandoned AU2019401465A1 (en) | 2018-12-22 | 2019-12-20 | Mitochondrial DNA deletions associated with endometriosis |
| AU2026202367A Pending AU2026202367A1 (en) | 2018-12-22 | 2026-03-27 | Mitochondrial DNA deletions associated with endometriosis |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2026202367A Pending AU2026202367A1 (en) | 2018-12-22 | 2026-03-27 | Mitochondrial DNA deletions associated with endometriosis |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220251655A1 (enExample) |
| EP (1) | EP3899050A2 (enExample) |
| JP (2) | JP7649745B2 (enExample) |
| KR (1) | KR20210107719A (enExample) |
| CN (1) | CN113227400A (enExample) |
| AU (2) | AU2019401465A1 (enExample) |
| CA (1) | CA3124497A1 (enExample) |
| SG (1) | SG11202106711YA (enExample) |
| WO (1) | WO2020132596A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112200270B (zh) * | 2020-11-17 | 2022-12-20 | 金弗康生物科技(上海)股份有限公司 | 一种用于纠正高通量组学数据缺失的数据分区填充方法 |
| GB202114374D0 (en) * | 2021-10-07 | 2021-11-24 | Univ Edinburgh | Endometriosis biomarker |
| GB202204595D0 (en) * | 2022-03-30 | 2022-05-11 | Univ Newcastle | Methods dor determining mitochondrial DNA damage |
| CN115404274A (zh) * | 2022-11-01 | 2022-11-29 | 广东省生殖科学研究所(广东省生殖医院) | 一种甲基化位点在子宫内膜异位症诊断和分型中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7871778B2 (en) * | 2007-04-25 | 2011-01-18 | The Regents Of The University Of California | Methods of diagnosing endometriosis |
| CA2719718C (en) * | 2008-03-28 | 2019-07-02 | Mdna Life Sciences Inc. | Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor |
-
2019
- 2019-12-20 SG SG11202106711YA patent/SG11202106711YA/en unknown
- 2019-12-20 JP JP2021536193A patent/JP7649745B2/ja active Active
- 2019-12-20 CN CN201980085361.1A patent/CN113227400A/zh active Pending
- 2019-12-20 AU AU2019401465A patent/AU2019401465A1/en not_active Abandoned
- 2019-12-20 CA CA3124497A patent/CA3124497A1/en active Pending
- 2019-12-20 KR KR1020217022010A patent/KR20210107719A/ko active Pending
- 2019-12-20 WO PCT/US2019/068098 patent/WO2020132596A2/en not_active Ceased
- 2019-12-20 US US17/415,507 patent/US20220251655A1/en not_active Abandoned
- 2019-12-20 EP EP19839765.5A patent/EP3899050A2/en active Pending
-
2025
- 2025-03-10 JP JP2025037093A patent/JP2025087867A/ja active Pending
-
2026
- 2026-03-27 AU AU2026202367A patent/AU2026202367A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3124497A1 (en) | 2020-06-25 |
| SG11202106711YA (en) | 2021-07-29 |
| AU2026202367A1 (en) | 2026-04-16 |
| KR20210107719A (ko) | 2021-09-01 |
| WO2020132596A3 (en) | 2020-07-23 |
| JP2025087867A (ja) | 2025-06-10 |
| JP2022514924A (ja) | 2022-02-16 |
| EP3899050A2 (en) | 2021-10-27 |
| WO2020132596A2 (en) | 2020-06-25 |
| JP7649745B2 (ja) | 2025-03-21 |
| US20220251655A1 (en) | 2022-08-11 |
| CN113227400A (zh) | 2021-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2026202367A1 (en) | Mitochondrial DNA deletions associated with endometriosis | |
| Cornu et al. | Urine TMPRSS2: ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer | |
| JP5666136B2 (ja) | 原発不明がんの原発巣を同定するための方法および材料 | |
| EP3283643B1 (en) | Means for diagnosing, predicting or monitoring pneumocystis pneumonia | |
| US20070065833A1 (en) | Method of detecting thyroid cancer | |
| CN113249491A (zh) | 用于诊断子宫内膜癌的生物标志物及其产品和应用 | |
| CN104711341B (zh) | Dlk1基因在制备胃肠道间质瘤诊断试剂中的应用 | |
| CN112626207B (zh) | 一种用于区分非侵袭性和侵袭性无功能垂体腺瘤的基因组合 | |
| KR20170027258A (ko) | 트립토파닐 티알엔에이 합성효소를 이용한 패혈증의 진단용 조성물과 진단 마커 검출 방법 | |
| KR20240114848A (ko) | 뇌졸중 진단 또는 예후 예측용 바이오마커 및 이의 용도 | |
| WO2026017138A1 (zh) | 脓毒症相关疾病生物标志物pax5及其用途 | |
| EP2382327B1 (en) | Biomarker | |
| US11371096B2 (en) | Blood biomarkers for appendicitis and diagnostics methods using biomarkers | |
| JPWO2010032797A1 (ja) | 乳癌の転移の判定方法及び血清の評価方法 | |
| CN107227358A (zh) | Numb在绝经后妇女原发性骨质疏松症诊断或预后中的用途 | |
| RU2830352C1 (ru) | Способ прогнозирования риска развития 3 степени злокачественности опухолевых клеток при раке молочной железы | |
| RU2828523C1 (ru) | Способ прогнозирования риска развития люминального подтипа рака молочной железы у женщин | |
| RU2830466C1 (ru) | Способ прогнозирования повышенного риска развития рака молочной железы 3-4 стадий заболевания у женщин | |
| KR101879498B1 (ko) | 바이오마커를 포함하는 임신 중 고혈압성 장애 진단용 조성물 | |
| RU2848546C1 (ru) | Набор олигонуклеотидов для генотипирования полиморфных маркеров хронического эндометрита rs3020450 гена ESR2 в клиническом материале методом полимеразной цепной реакции с детекцией результатов амплификации в режиме реального времени | |
| JP7847450B2 (ja) | アトピー性皮膚炎の症度悪化の検出方法 | |
| CN110577995A (zh) | 男性骨质疏松症的诊断标志物 | |
| CN109988834A (zh) | 血浆外泌体分子标志物has-miR-219a-5p及应用 | |
| EP3321683A1 (en) | Method for evaluating lymph node metastatic potential of endometrial cancer | |
| WO2022196750A1 (ja) | 子宮体がんのリンパ節転移能の評価方法のためのコンパニオンマーカー |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |